TABLE OF CONTENTS
- Biomedical Business and Legal Management Strategies
- Study, learn, and explore biotechnology law, science and technology!
- Biotech continuum
- How US Multinationals Profit from Tax Havens
- Ireland is the world’s biggest corporate “tax haven”
- Setting up a company in Ireland - 18 things you need to know
- Jersey Exempt Company Benefits
- Doing Business in the UK
- UK Immigration Business Visas, Residency, and path to citizenship
- UK Corporations
- How to form a UK Limited Liability Company for £18.39
- Singapore Global Technology Hub
- Step by Step Guide for Starting a California Nonprofit
- Limitations and Best Practices for Using Non-Competition Agreements to Protect Company Trade Secrets
- Developing a Trade Secret Protection Program to Reduce Risk and Increase Court Enforcement
- Survival of the Smartest: Funding Sources for Biotech and Life Sciences Companies
- Equity Crowdfunding Great Opportunity For Biotech
- Physicians Research Investment Trust (PRIT)
- Limited Partnership Example
- The Subscription Agreement
- Private Placement Memorandum (“Memorandum”)
- Advisory Board Agreement
- Institutional Review Board
- The Term Sheet
- Amended and Restated Bylaws for Biotech Inc
- Strategic Business Plan & Investor Package
- BEST Plain-preferred
- Memorandum of Terms
- BEST Postmoney Safe Example
- BEST Postmoney safe #2 MFN ONLY
- BEST Post-money Valuation Cap #3
- Subscription Agreement 3.0
- BEST Post-money valuation cap with discount version 1.0
- Pro Rata Agreement
- Restated Certificate of Incorporation
- Series Seed Preferred Stock Investment Agreement
- Terms For Private Placement Of Series Seed Preferred Stock
- Series Seed Preferred Stock Investment Agreement 2.0
- USPTO announces COVID-19 Prioritized Examination Pilot Program for small and micro entities
- CAR T-Cell Cancer Therapy Review
Biotech continuum
Two factors play a critical role in forming companies that earn long-term success. First, the quality of the original idea and founding vision behind the company's formation must always remain constant—even when the business grows larger and adapts to change. Second, the original founders and entrepreneurs should remain and lead the company through the inevitable peaks and troughs.
Although the founders' roles and responsibilities will no doubt change, founders tend to confer the same enthusiasm and passion that they did when they first set up their business, which keeps an entrepreneurial spirit at the heart of the company.
Timing: predicting the future
Some people argue that timing is luck and that you can't plan for things. They are wrong. You can plan, but only if you are open-minded and position your start-up correctly.
Forming strategic alliances with corporate partners as soon as possible can provide valuable endorsement in addition to financial support.
Starting a sustainable biotech company means having the right blend of management, access to cash, adaptability, timing and location. By recognizing, leveraging and capitalizing on all the possible opportunities, you will give yourself a head start on the road to building a successful company.
There’s never been a more exciting time to be a biotech startup. It is reported that “Big Pharma” companies have $100 billion in cash reserve for M&A of new biotech companies. There are plenty of Holy Grail areas to focus on. How can you argue with this logic? Now is the time to jump in.
Biomedical Business and Legal Management Strategies
Learn the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies.
Going beyond simple 'science for non-scientists' or 'mini MBA' offerings, volume four (4) of this book series describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.
Study, learn, and explore biotechnology law, science and the biopharma industry!
- Assess the potential therapeutic value of discoveries emanating from advanced research in the life sciences and understand ways to accelerate these discoveries into therapeutics, and medical devices.
- Lead science-based organizations, including businesses and non-profits, with an understanding of research, business models, intellectual property and regulatory strategies.
- Determine the most promising strategy for science-based organizations, including novel ways for expanding access to crucial investment funds and securities offerings.
- Understand the financial underpinnings of investment decisions in the life sciences, including real-option approaches to investments, as well as the role of scientific, commercial, and regulatory uncertainties affecting biopharma companies.
